For the GSTM1 gene deletion, the same pattern of associations was observed: the acrylamide-associated risk of endometrial cancer was only increased in women with at least one copy of the GSTM1 gene but there was no statistically significant interaction with acrylamide intake. This evidence concerns the gene GSTM1 and endometrial cancer.